These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 539425)

  • 41. [Polymorphism of myosin in muscle and nonmuscle cells (author's transl)].
    Strzelecka-Gołaszewska H; Piwowar U
    Postepy Biochem; 1980; 26(4):517-57. PubMed ID: 7017641
    [No Abstract]   [Full Text] [Related]  

  • 42. [New class I anti-arrhythmia agents].
    Touboul P
    Rev Prat; 1986 Nov; 36(53):3147-52. PubMed ID: 3101159
    [No Abstract]   [Full Text] [Related]  

  • 43. [Importance of pharmacokinetic studies in the clinical phase of experimentation with anti-arrhythmia agents].
    Jaillon P
    Arch Mal Coeur Vaiss; 1981 Dec; 74 Spec No():57-64. PubMed ID: 6803702
    [No Abstract]   [Full Text] [Related]  

  • 44. [Metabolism and anti-convulsive action of 2-[beta-pyridyl-(2")-ethenyl]-3-(2'-methylphenyl)-quinazolinone-(4) (B169)].
    Mori A; Mukawa J; Okusu H; Kobayashi K; Mizuno A
    No To Shinkei; 1969 Mar; 21(3):271-5. PubMed ID: 5819332
    [No Abstract]   [Full Text] [Related]  

  • 45. Modeling of high-affinity binding of the novel atrial anti-arrhythmic agent, vernakalant, to Kv1.5 channels.
    Eldstrom J; Fedida D
    J Mol Graph Model; 2009 Oct; 28(3):226-35. PubMed ID: 19713139
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Reduction of aconitine and adrenaline tachycardia by the antifibrillating substance trimepranol in the rat heart in situ and in the isolated frog heart (comparative study) (author's transl)].
    Slavícek J; Rosol Z
    Sb Lek; 1977 Feb; 79(2):58-63. PubMed ID: 841267
    [No Abstract]   [Full Text] [Related]  

  • 47. Absorption, excretion and metabolism of 1,5-dimorpholino-3-(1-naphthyl)-pentane (DA 1686) in rats and rabbits.
    Coppi G; Bonardi G; Perego R
    Arzneimittelforschung; 1968 Oct; 18(10):1343-5. PubMed ID: 5755717
    [No Abstract]   [Full Text] [Related]  

  • 48. [Effects of denudatine on experimental arrhythmia and heart function (author's transl)].
    Jin LS; Zhou YP; Zeng GY
    Zhongguo Yao Li Xue Bao; 1982 Jun; 3(2):104-8. PubMed ID: 6214142
    [No Abstract]   [Full Text] [Related]  

  • 49. Electrophysiological evidence that local anesthetics and antiarrhythmic drugs bind to a specific receptor site in cardiac sodium channels: displacement of bupivacaine by lidocaine.
    Clarkson CW; Hondeghem LM
    Proc West Pharmacol Soc; 1984; 27():23-5. PubMed ID: 6093130
    [No Abstract]   [Full Text] [Related]  

  • 50. [The anti-arrhythmia activity of quinazopyrine].
    Stets VR; Beregovaia EG; Dunaev VV; Storozhuk BG; Favoritov VN; Stoliarchuk AA; Mazur AI
    Farmakol Toksikol; 1990; 53(3):15-7. PubMed ID: 2387373
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Auricular vagal arrhythmia (author's transl)].
    Schoenfeld P
    Rev Med Brux; 1980 Mar; 1(3):161-3. PubMed ID: 7466016
    [No Abstract]   [Full Text] [Related]  

  • 52. [Agranulocytosis induced by chloroacetylajmaline (author's transl)].
    Cassuto JP; Chichmanian RM; Dujardin P; Audoly P
    Therapie; 1980; 35(3):375-80. PubMed ID: 7423430
    [No Abstract]   [Full Text] [Related]  

  • 53. [Anti-arhythmic properties of new N,N'-substituted benzamidines (author's transl)].
    Narcisse G; Huguet F; Loiseau P; Moreau RC; Choay P
    Ann Pharm Fr; 1979; 37(7-8):325-30. PubMed ID: 556213
    [No Abstract]   [Full Text] [Related]  

  • 54. [Influence of magnesium sulfate on the sizes of myocardial infarction in rabbits].
    Wang SR; Wu XN; Lai XQ; Cai BH; Pan YS; Li AZ; Huang LY
    Zhongguo Yao Li Xue Bao; 1988 Jan; 9(1):30-3. PubMed ID: 3188930
    [No Abstract]   [Full Text] [Related]  

  • 55. [Control of muscle contraction--role of troponin (author's transl)].
    Maruyama K; Ebashi S
    Tanpakushitsu Kakusan Koso; 1975 Mar; 20(4):426-40. PubMed ID: 1099619
    [No Abstract]   [Full Text] [Related]  

  • 56. [Preventive effect of quinazoline derivative GT-28 on rabbits' experimental atherosclerosis (author's transl)].
    Kobayashi M; Moriya K; Tkaashima Y; Sugimoto A; Ishikawa M
    Tokyo Ika Shika Daigaku Iyo Kizai Kenkyusho Hokoku; 1981; 15():45-53. PubMed ID: 6955909
    [No Abstract]   [Full Text] [Related]  

  • 57. [No relationship between myocardial cAMP and positive inotropic effects of convallatoxin (author's transl)].
    Shih L; Wu CQ; Wang DS; Liu SZ; Li YM; Hu GS; Zhou ZQ; Pan JX
    Zhongguo Yao Li Xue Bao; 1980 Dec; 1(2):100-4. PubMed ID: 6121447
    [No Abstract]   [Full Text] [Related]  

  • 58. [Anti-arrhythmia properties of pyromecaine].
    Zakusov VV; Prianishnikova NT; Cherniakova IV; Samvelian VM; L'vov MV
    Farmakol Toksikol; 1983; 46(5):32-7. PubMed ID: 6628657
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Nor-tropan hydantoins n-substituted: action on smooth muscle, and its antiarrhythmic and anticonvulsant effects (author's transl)].
    García Sacristán A; Illera Martín M; Sanz Sánchez F
    Arch Farmacol Toxicol; 1977 Apr; 3(1):57-66. PubMed ID: 901017
    [No Abstract]   [Full Text] [Related]  

  • 60. Do related kappa agonists produce similar effects on cardiac ion channels?
    Pugsley MK; Hayes ES; Saint DA; Walker MJ
    Proc West Pharmacol Soc; 1995; 38():25-7. PubMed ID: 7480011
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.